Healthcare provider profile · identity verified

Jessica Patterson, NP

Nurse Practitioner · SPRINGFIELD, VA · NPI 1225692973

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	835	194
Amlodipine Besylate	Amlodipine Besylate	560	141
Gabapentin	Gabapentin	404	97
Furosemide	Furosemide	310	76
Lisinopril	Lisinopril	260	59
Metformin Hcl	Metformin Hcl	259	65
Jardiance	Empagliflozin	248	55
Tamsulosin Hcl	Tamsulosin Hcl	229	41
Losartan Potassium	Losartan Potassium	228	67
Trulicity	Dulaglutide	212	44
Pantoprazole Sodium	Pantoprazole Sodium	201	43
Carvedilol	Carvedilol	197	43
Albuterol Sulfate Hfa	Albuterol Sulfate	175	64
Omeprazole	Omeprazole	162	34
Eliquis	Apixaban	159	37
Levothyroxine Sodium	Levothyroxine Sodium	159	31
Nifedipine Er	Nifedipine	145	39
Trazodone Hcl	Trazodone Hcl	134	36
Rosuvastatin Calcium	Rosuvastatin Calcium	128	35
Donepezil Hcl	Donepezil Hcl	123	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	120	45
Diclofenac Sodium	Diclofenac Sodium	118	56
Hydrochlorothiazide	Hydrochlorothiazide	115	36
Pravastatin Sodium	Pravastatin Sodium	114	19
Hydralazine Hcl	Hydralazine Hcl	111	30
Metoprolol Succinate	Metoprolol Succinate	111	28
Ezetimibe	Ezetimibe	105	20
Clopidogrel	Clopidogrel Bisulfate	101	22
Ozempic	Semaglutide	100	38
Escitalopram Oxalate	Escitalopram Oxalate	97	28
Levetiracetam	Levetiracetam	94	13
Allopurinol	Allopurinol	90	23
Duloxetine Hcl	Duloxetine Hcl	88	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	26
Sertraline Hcl	Sertraline Hcl	80	19
Mirtazapine	Mirtazapine	76	20
Tramadol Hcl	Tramadol Hcl	72	32
Famotidine	Famotidine	71	22
Fluticasone Propionate	Fluticasone Propionate	71	26
Memantine Hcl	Memantine Hcl	70	suppressed
Glipizide Er	Glipizide	66	14
Montelukast Sodium	Montelukast Sodium	65	20
Metoprolol Tartrate	Metoprolol Tartrate	62	17
Calcitriol	Calcitriol	58	suppressed
Olanzapine	Olanzapine	57	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	56	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	53	45
Quetiapine Fumarate	Quetiapine Fumarate	53	14
Triamcinolone Acetonide	Triamcinolone Acetonide	53	27
Meloxicam	Meloxicam	52	14
Azithromycin	Azithromycin	50	44
Prednisone	Prednisone	50	19
Finasteride	Finasteride	49	11
Olmesartan Medoxomil	Olmesartan Medoxomil	49	12
Aripiprazole	Aripiprazole	47	suppressed
Nystatin	Nystatin	46	25
Citalopram Hbr	Citalopram Hydrobromide	44	suppressed
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Hydrocortisone	Hydrocortisone	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Chlorthalidone	Chlorthalidone	39	12
Latanoprost	Latanoprost	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	15
Atenolol	Atenolol	36	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Simvastatin	Simvastatin	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Mupirocin	Mupirocin	33	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Ventolin Hfa	Albuterol Sulfate	33	15
Divalproex Sodium	Divalproex Sodium	32	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Methylprednisolone	Methylprednisolone	32	28
Cephalexin	Cephalexin	31	28
Pregabalin	Pregabalin	31	suppressed
Lidocaine	Lidocaine	30	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	26
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	28	suppressed
Naloxone Hcl	Naloxone Hcl	27	15
Valsartan	Valsartan	27	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	25	suppressed
Ibuprofen	Ibuprofen	25	12
Myrbetriq	Mirabegron	25	suppressed
Torsemide	Torsemide	25	suppressed
Cefdinir	Cefdinir	24	23
Doxycycline Hyclate	Doxycycline Hyclate	24	22
Entresto	Sacubitril/Valsartan	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Celecoxib	Celecoxib	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Colchicine	Colchicine	22	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Potassium Chloride	Potassium Chloride	19	14
Bupropion Xl	Bupropion Hcl	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Fluconazole	Fluconazole	17	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Baclofen	Baclofen	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Risperidone	Risperidone	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Clonidine	Clonidine	15	suppressed
Haloperidol	Haloperidol	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Sevelamer Hcl	Sevelamer Hcl	15	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	15	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Anastrozole	Anastrozole	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Asenapine Maleate	Asenapine Maleate	13	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Levofloxacin	Levofloxacin	13	11
Metformin Er Osmotic	Metformin Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Glucagon Emergency Kit	Glucagon	12	12
Paliperidone Er	Paliperidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Etravirine	Etravirine	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Lactulose	Lactulose	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ritonavir	Ritonavir	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Xtandi	Enzalutamide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error